| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |